Powell Andrew Kenneth William
Insider CIK 1304113 · LNDC Director · MDVN SVP, General Counsel & Crp Sec · ITMN EVP, GC & Secretary · CRTX EVP, General Counsel · ACRS Director · THOR Director · SBTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 33,523 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2024-03-04 | 2024-03-05 | 6,000 | $1.25 | $7.5K | 28,863 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2024-03-01 | 2024-03-05 | 8,500 | $1.23 | $10.5K | 22,863 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 14,363 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 4,660 | — | $0 | 4,660 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | G Gift | 2022-11-08 | 2023-01-20 | 4,000 | — | $0 | 9,856 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2022-06-10 | 2022-06-13 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LNDC LANDEC CORP \CA\ | M Exercise deriv | 2022-06-04 | 2022-06-07 | 7,059 | $9.50 | $67.1K | 0 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award | 2022-06-04 | 2022-06-07 | 7,059 | $9.50 | $67.1K | 27,477 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 13,856 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 4,507 | — | $0 | 4,507 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 15,750 | — | $0 | 15,750 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award deriv | 2022-05-31 | 2022-06-02 | 9,474 | — | $0 | 9,474 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | G Gift | 2022-05-16 | 2022-06-06 | 709 | — | $0 | 10,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | G Gift | 2021-11-23 | 2021-12-03 | 5,500 | — | $0 | 11,209 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2021-06-04 | 2021-09-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award deriv | 2021-06-04 | 2021-06-08 | 7,059 | — | $0 | 7,059 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 12,250 | — | $0 | 12,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 3,356 | — | $0 | 3,356 | SEC↗ |
| LNDC LANDEC CORP \CA\ | M Exercise deriv | 2021-06-01 | 2021-06-03 | 8,303 | $11.64 | $96.6K | 0 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award | 2021-06-01 | 2021-06-03 | 8,303 | $11.64 | $96.6K | 20,418 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2020-12-03 | 2020-12-07 | 21,009 | — | $0 | 21,009 | SEC↗ |
| LNDC LANDEC CORP \CA\ | M Exercise deriv | 2020-10-15 | 2020-10-19 | 2,200 | — | $0 | 0 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award | 2020-10-15 | 2020-10-19 | 2,200 | $10.36 | $22.8K | 12,115 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 16,709 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 16,500 | — | $0 | 16,500 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award deriv | 2020-06-01 | 2020-06-02 | 8,303 | — | $0 | 8,303 | SEC↗ |
| LNDC LANDEC CORP \CA\ | M Exercise deriv | 2020-05-28 | 2020-05-29 | 6,000 | — | $0 | 0 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award | 2020-05-28 | 2020-05-29 | 6,000 | $10.99 | $65.9K | 9,915 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 8,876 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 9,376 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 27,015 | $54.00 | $1.46M | 0 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 6,389 | $55.60 | $355.2K | 0 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award deriv | 2019-10-15 | 2019-10-17 | 2,200 | — | $0 | 2,200 | SEC↗ |
| THOR Synthorx, Inc. | A Award deriv | 2019-06-07 | 2019-06-10 | 6,389 | — | $0 | 6,389 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| LNDC LANDEC CORP \CA\ | M Exercise deriv | 2019-05-30 | 2019-05-30 | 2,915 | — | $0 | 0 | SEC↗ |
| LNDC LANDEC CORP \CA\ | M Exercise | 2019-05-30 | 2019-05-30 | 2,915 | $9.91 | $28.9K | 3,915 | SEC↗ |
| LNDC LANDEC CORP \CA\ | A Award deriv | 2019-05-28 | 2019-05-30 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LNDC LANDEC CORP \CA\ | M Exercise deriv | 2019-01-30 | 2019-01-31 | 2,915 | — | $0 | 2,915 | SEC↗ |
| LNDC LANDEC CORP \CA\ | P Buy | 2019-01-11 | 2019-01-14 | 525 | $11.62 | $6.1K | 1,000 | SEC↗ |
| THOR Synthorx, Inc. | A Award deriv | 2018-12-19 | 2018-12-21 | 27,015 | — | $0 | 27,015 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2018-05-16 | 2018-05-17 | 500 | $19.12 | $9.6K | 500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2017-01-25 | 2017-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 40,860 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 14,474 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 38,530 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer | 2016-09-28 | 2016-09-30 | 22,920 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | U Tender | 2016-09-28 | 2016-09-30 | 5,597 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2016-06-06 | 2016-06-06 | 2,578 | $60.42 | $155.8K | 28,517 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2016-02-29 | 2016-03-02 | 38,530 | — | $0 | 38,530 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-02-18 | 2016-03-02 | 9,300 | — | $0 | 38,250 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-02-18 | 2016-03-22 | 9,300 | — | $0 | 29,930 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2015-06-01 | 2015-06-02 | 20,430 | — | $0 | 20,430 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2015-05-27 | 2015-05-29 | 10,215 | — | $0 | 10,315 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 5,250 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 117,500 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 26,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 17,500 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 24,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer | 2014-09-29 | 2014-10-01 | 304 | $74.00 | $22.5K | 0 | SEC↗ |
| ITMN INTERMUNE INC | U Tender | 2014-09-29 | 2014-10-01 | 7,750 | $74.00 | $573.5K | 304 | SEC↗ |
| ITMN INTERMUNE INC | G Gift | 2014-09-15 | 2014-09-17 | 677 | — | $0 | 30,250 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-09-02 | 2014-09-03 | 7,500 | — | $0 | 117,500 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-09-02 | 2014-09-03 | 7,500 | $15.00 | $112.5K | 38,427 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-09-02 | 2014-09-03 | 7,500 | $73.47 | $551.0K | 30,927 | SEC↗ |
| ITMN INTERMUNE INC | G Gift | 2014-06-09 | 2014-06-11 | 100 | — | $0 | 30,927 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-05-30 | 2014-06-03 | 500 | $39.32 | $19.7K | 31,027 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-03 | 5,250 | — | $0 | 5,250 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-03 | 3,500 | — | $0 | 3,500 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-05-29 | 2014-06-03 | 500 | $39.56 | $19.8K | 31,527 | SEC↗ |
| ITMN INTERMUNE INC | J Other | 2014-04-30 | 2014-06-03 | 1,277 | $12.31 | $15.7K | 32,027 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-09-09 | 2014-10-01 | 22,500 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-09-09 | 2013-09-10 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-09-09 | 2013-09-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award | 2013-09-09 | 2013-09-10 | 30,000 | — | $0 | 30,750 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer | 2013-08-30 | 2013-08-30 | 27,645 | — | $0 | 89,785 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award | 2013-03-05 | 2013-03-07 | 21,375 | — | $0 | 117,430 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | F Tax w/h | 2012-09-10 | 2012-09-12 | 2,045 | $6.27 | $12.8K | 96,055 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award deriv | 2012-02-29 | 2012-04-03 | 50,000 | — | $0 | 50,000 | SEC↗ |